SCHEMBL3299387

SCHEMBL3299387

CC(C)(C)CC(C)(C)c1ccc([SiH](O[SiH](c2ccc(C(C)(C)CC(C)(C)C)cc2)c2ccc(C(C)(C)CC(C)(C)C)cc2)c2ccc(C(C)(C)CC(C)(C)C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.53
CYP3A4 P08684 6/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
MDH1 P40925 7/20 0.35
MDH2 P40926 7/20 0.35
HIF1A Q16665 3/20 0.35
CYP2D6 P10635 2/20 0.35
USP2 O75604 4/20 0.34
MAPT P10636 4/20 0.34
LMNA P02545 3/20 0.34
MEN1 O00255 3/20 0.34
TP53 P04637 3/20 0.34
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
SLC6A3 Q01959 3/20 0.34
KMT2A Q03164 3/20 0.34
KCNH2 Q12809 3/20 0.34
ESR1 P03372 3/20 0.34
APAF1 O14727 2/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3297583 0.82 SHBG (0.41) SHBGCYP3A4SMN1; SMN2HIF1ACYP2D6
SCHEMBL3298666 0.78 SHBG (0.39) SHBGCYP3A4SMN1; SMN2MDH1MDH2
SCHEMBL3294498 0.76 TSHR (0.46) SMN1; SMN2MAPTLMNAALDH1A1TSHR
SCHEMBL3294314 0.76 SHBG (0.32) SHBGCYP3A4SMN1; SMN2
SCHEMBL3299388 0.74 CNR2 (0.50) CNR1
SCHEMBL10515698 0.73 SHBG (0.67) SHBGCYP3A4SMN1; SMN2MDH1MDH2
SCHEMBL3294363 0.73 CYP3A4 (0.31) CYP3A4SMN1; SMN2
SCHEMBL3303307 0.73 SHBG (0.46) SHBGCYP3A4SMN1; SMN2MDH1MDH2
SCHEMBL3297694 0.73 SHBG (0.46) SHBGCYP3A4SMN1; SMN2MDH1MDH2
SCHEMBL28747587 0.72 CYP3A4 (0.61) SHBGCYP3A4SMN1; SMN2MDH1MDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 SHBG 2999/4885CYP3A4 1577/4885SMN1; SMN2 1035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.